Highlights
KLSE: KPJ (5878)       KPJ HEALTHCARE BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
0.82   -0.025 (2.96%)  0.795 - 0.84  4,669,900
Analyze this stock with MQ Trader system

Financials


Market Cap: 3,642 Million

Market Cap 3,642 Million
NOSH 4,442 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 10-Jun-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 10-Jun-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  31-Mar-2020 [#1]

Latest Quarter: 31-Mar-2020 [#1]
Announcement Date 10-Jun-2020
Next Quarter: 30-Jun-2020
Est. Ann. Date: 30-Aug-2020
Est. Ann. Due Date: 29-Aug-2020
QoQ | YoY   -54.13%  |    -1.52%

Annual (Unaudited) ( EPS: 4.76, P/E: 17.23 )

Revenue | NP to SH 3,604,364  |  211,368
RPS | P/RPS 81.14 Cent  |  1.01
EPS | P/E | EY 4.76 Cent  |  17.23  |  5.80%
DPS | DY | Payout % 1.92 Cent  |  2.34%  |  40.42%
NAPS | P/NAPS 0.41  |  1.98
YoY   17.79%
NP Margin | ROE 6.29%  |  11.51%
F.Y. | Ann. Date 31-Dec-2019  |  26-Feb-2020

T4Q Result ( EPS: 4.75, P/E: 17.28 )

Revenue | NP to SH 3,581,909  |  210,775
RPS | P/RPS 80.64 Cent  |  1.02
EPS | P/E | EY 4.75 Cent  |  17.28  |  5.79%
DPS | DY | Payout % 1.93 Cent  |  2.35%  |  40.77%
NAPS | P/NAPS 0.41  |  1.98
QoQ | YoY   -0.28%  |    19.70%
NP Margin | ROE 6.25%  |  11.45%
F.Y. | Ann. Date 31-Mar-2020  |  10-Jun-2020

Annualized Result ( EPS: 3.47, P/E: 23.63 )

Revenue | NP to SH 3,536,636  |  154,132
RPS | P/RPS 79.62 Cent  |  1.03
EPS | P/E | EY 3.47 Cent  |  23.63  |  4.23%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -27.08%  |    -1.52%
NP Margin | ROE 4.58%  |  8.38%
F.Y. | Ann. Date 31-Mar-2020  |  10-Jun-2020



Business Performance

Business Performance (By Quarter)

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 0 / 4 0.00% 0 / 8 0.00%
Total Positive Profit Years 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Positive Profit 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Profit Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted EPS Growth 0 / 4 0.00% 0 / 8 0.00%
Total Dividend Years 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Dividend 4 / 4 100.00% 8 / 8 100.00%
Continuous Quarters Of Dividend Growth 1 / 4 25.00% 1 / 8 12.50%
Continuous Quarters Of Adjusted Dps Growth 1 / 4 25.00% 1 / 8 12.50%
Average ROE 2.99% 2.73%
Average Net Profit Margin 6.19% 5.84%

Business Performance (By Year)

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Years Of Revenue Growth 5 / 5 100.00% 10 / 10 100.00%
Total Positive Profit Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Positive Profit 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Profit Growth 4 / 5 80.00% 4 / 10 40.00%
Continuous Years Of Adjusted EPS Growth 4 / 5 80.00% 4 / 10 40.00%
Total Dividend Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Dividend 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Dividend Growth 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Adjusted Dps Growth 0 / 5 0.00% 0 / 10 0.00%
Average ROE 15.44% 14.72%
Average Net Profit Margin 5.59% 6.10%

Key Result

Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 3,581,909 3,536,636 3,604,364 2,651,103 3,176,109
NP to SH 210,775 154,132 211,368 149,136 168,522
Dividend 85,936 85,585 85,426 79,645 79,571
Adjusted EPS 4.75 3.47 4.76 3.36 3.79
Adjusted DPS 1.93 1.93 1.92 1.79 1.79

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.


Growth

Growth (By Quarter)

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue -6.34% 1.85% 1.85% -1.26% 1.99%
NP to Owner -54.13% -1.52% -1.52% -26.87% -20.32%
Dividend 0.19% -0.85% -0.85% -0.41% -1.11%
Adj. EPS -54.13% -1.52% -1.52% -26.87% -20.32%
Adj. DPS 0.19% -0.85% -0.85% -0.41% -1.11%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

Growth (By Year)

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue -0.62% 12.78% 35.11% -1.88% 11.35% 33.40% 8.96% 13.48% 35.96%
NP to Owner -0.28% 25.07% 41.33% -27.08% -8.54% 3.35% 17.79% 25.42% 41.73%
Dividend 0.60% 8.00% 7.90% - % - % - % -1.92% 7.36% 7.26%
Adj. EPS -0.28% 25.07% 41.33% -27.08% -8.54% 3.35% 17.79% 25.42% 41.73%
Adj. DPS 0.60% 8.00% 7.90% - % - % - % -1.92% 7.36% 7.26%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Trade this stock for as low as 0.05% brokerage. Find out more.
  4 people like this.
 
Junqi Over the years, kpj had bought back millions of its own shares.
Its about the cheapest healthcare stocks in Bursa.
Time to go up
22/07/2020 4:36 PM
captain star Tmr another round guys..!!!comeon!!
22/07/2020 8:19 PM
hksoon Intraday Nova highest up to Rm1.14, consider for long term hold and investing. Comfort glov also can put into your watch list.
Tuan-tuan dan Puan-puan sila membuat pertimbangan bahawa perlaburan pada counter Nova Wellness adalah buat jangka masa yang panjang. Permintaan kpd hand sanitizer masih kuat seperti Harimau Malaya
22/07/2020 10:38 PM
Virus t Why KPJ is next gem for post covid-19?
Based on Fundamental analysis our current PE guideline is approx 57.14 (Based on 1.75% of BNM base rate) however KPJ PE=17.47@RM0.83 thus the actual price for KPJ should be RM2.71.
Covid-19 only good for medical sector (more clearly is protective medical equipment “glove, mask, face shield and etc” and diagnosis instrument “thermo scanners, PCR tester and etc” For Malaysia top glove, harta, kossan and supermx all are the first round winners.
For the last stage of vaccination development, now is the time to look for the next gem but unfortunately our country is impossible to produce these vaccine. The only vaccine we can get is import and we hv 20+mil ppl need to be vaccinated. Early stage of vaccine must be very expensive and gov won’t sponsor. We only can get vaccinated through private hospital no matter for travel or job requirement or just stay safe. Based on 2019, KPJ recorded 2,629,878 outpatients @ net profit 226.7mil with 28 hospitals overall the state. If half of 20mil ppl go KPJ for vaccination so approx net profit can reach up to 1bil. And u need to know tat those vaccine isn’t 1 injection for lifetime (like seasonally flu vaccine) and must get it semi or annually. RM1k-2k per vaccine per yrs for everyone to stay safe is new normal of post covid-19. And it is long term investment value of KPJ.
23/07/2020 10:36 AM
JaBerry Time to collect b4 up. Other already up.
23/07/2020 10:46 AM
stevenckheng Q2 report bad, can buy now but dont chase high
23/07/2020 1:16 PM
Virus t There are 23 potential vaccines developed and 3 candidates already passed the clinical trial and go for final stage of testing.
1. Moderna vaccine enter the final stage of human trials for its COVID-19 vaccine on July 27.
2. Oxford-AstraZeneca Covid-19 vaccine show good immune responses without side effect.
3. Chinese-made vaccine from Sinovac Biotech at final stage of testing in Brazil.
23/07/2020 1:36 PM
Virus t PATHOLOGY SERVICES - LABLINK (M) SDN BHD provide laboratory/pathology services to the KPJ Group. It manages the pathology laboratories in KPJ’s network of hospitals. Lablink also conducts clinical tests for more than 100 non-KPJ institutions (including hospitals under the Ministry of Health and University Hospitals) as wellas general practitioners’ clinics across Malaysia. Lablink is the first lab in Malaysia to be certified with Bio-Safety Level 3 (BSL3) facilities which allows testing of highly infectious diseases (according to World Health Organization (WHO) standards). In Mar 2020, Lablink was one of the private laboratories listed by the Ministry of Health (MOH) to perform COVID-19 rRT-PCR (i.e. real-time reverse transcription polymerase chain reaction) by testing specimens received from hospitals: both from walk-in members of the public as well as hospital inpatients. Lablink recorded revenue of RM102.2 million in 2019.
24/07/2020 8:43 AM
Virus t The KPJ group of Hospitals classified Covid 19 rRT-PCR test according to urgent (result within 24 hours) and routine (beyond 24 hours). The COVID-19 testing capacity has been ramped up and Lablink has been able to test and report about 1,500-3,000 samples in a day in May 2020. The total number of samples, as at the end of May 2020 was in excess of 70,000; of which the KPJ-Group of Hospitals Nationwide contributed to almost 75% of the tests while the balance was from non-KPJ hospitals and the Ministry of Health.
24/07/2020 8:44 AM
Virus t Regardless of Covid 19 outbreak, KPJ remain resilient of its business model. The group switches over to ramp up testing services and can generate augur profit to offset any downturn during outbreak.
24/07/2020 8:54 AM
Junqi KPJ needs a new business model to spur growth, ie employing specialists.Presently specialists work independently. I believe this new model is underway with scholarships given to doctors for specialist training in its postgrad. University
25/07/2020 1:56 PM
DickyMe KPJ 's business model is okay.
What needs to change is racism and scarcity mentality.

It must learn what is hospitality and integrity.
It must amputate leeches in the form of blood sucking vendors and politicians. It must learn how to serve every citizen without discrimination.

It must not function like a job creating entity.
Investors are not fools to part with their money.
25/07/2020 2:18 PM
Takers Lousy counter hari-hari turun
27/07/2020 8:56 PM
Kenzo8 what is the reason of dropping?
27/07/2020 11:45 PM
Virus t PHARMASERV ALLIANCES SDN BHD (PASB) is KPJ’s centralized wholesaler and distributor of pharmaceutical, medical disposables and other hospital related products. Its clients are the KPJ network of hospitals and companies, as well as external clients within the government sector and other healthcare sector players. PASB is able to achieve profitable growth and retain a competitive edge by transferring cost savings to customers. In 2019, its revenue increased to RM451.1 million.
28/07/2020 8:24 AM
Virus t Moderna Inc is planning to price its coronavirus vaccine at US$50 to $60 per course, at least $11 more than another vaccine from Pfizer Inc and BioNTech.
29/07/2020 7:48 AM
Sebastian Power beli this counter then keep in freezer. After 5-10years only see it
29/07/2020 12:11 PM
hksoon Mr.President D.Trump will lose the election in this November 2020 or not ? If yes how about Dow index will plunge or up ? Please experts here who could explain ? If Trump lose how about KLCI, healthcare sector and glove conuters ? Could further uptrend ? or Plunge ... ?
Para hadirin dan tuan tuan dan puan puan, keputusan piliharaya utk Amerika Syarikat pada bulan 11 ni jika En. D.Trump terkandas apa akan terjadi kepada KLCI,healthcare sector dan harga saham sarung tangan di Malaysia ? siapa pakar pakar saham di sini boleh tolong lah explain. Tks
30/07/2020
30/07/2020 1:48 PM
Investeye Take opportunity to accumulate and average down the cost
30/07/2020 3:56 PM
Shadows Queue in 7.80
30/07/2020 4:53 PM
smkts123 hksoon. Sebab itu rally healthcare glove ini memang rush cepat sikit sblm November 2020. Supaya harga boleh menggambarkan potential business. Jatuh atau naik tentu berlaku sebab market Tak suka news. Tetapi trending healthcare glove technology akan terus naik untuk satu tempoh at least 12 bulan
30/07/2020 8:18 PM
smkts123 Rally 12 bulan biasa bagi mana2 rally di Bursa sejak dulu...1997 currency rally....2000 dotcom rally.......1MDB 2009 property/construction rally.......2019 oilgas rally.......2020 mega rubber gloves healthcare rally
30/07/2020 8:22 PM
smkts123 Semua anggaran 12 month rallies
30/07/2020 8:22 PM
hksoon ribu dan jutaan terima kasih kpd smkts123. b4 november dah super bull run pada counter medical related spt Nova wellness, Comfort dan BCM Alliance dll. harap juga En.D.Trump akan kekel berkuasa dan kembali dalam arena politikus Amerika.
30/07/2020 11:01 PM
freddiehero haha funny la..
30/07/2020 11:03 PM
freddiehero why epf keep buying?
30/07/2020 11:05 PM
hksoon theedgemarkets.com News report : KPJ Healthcare Bhd is disposing of its 80% stake in an Indonesian company that owns a hospital in Jakarta for RM28 million, because of difficulty experienced in complying with the licensing and regulatory requirements. The company, PT Khidmat Perawatan Jasa Medika (KPJM), operates a specialist hospital known as RS Medika Permata Hijau.
01/08/2020 6:02 PM
jazz2pai what effects next week ?
01/08/2020 10:49 PM
Takers Not a positive news for KPJ.
01/08/2020 11:32 PM
Sebastian Power Good news la. Last time only spent RM15mil bought, now RM28mil disposed
01/08/2020 11:33 PM
jazz2pai hope tomorrow up the price..
02/08/2020 4:22 PM
hksoon got something wrong with their management of spending RM15mil bought, and now RM28mil disposed. KENA BALIK SEKOLAH BeLAJAR LAGI KUNCI KIRA-KIRA
02/08/2020 11:07 PM
Value_Investor_888 Because of difficulty experienced in complying with the licensing and regulatory requirements. KPJ disposed PT Khidmat Perawatan Jasa Medika (KPJM) at price of RM28 mil, this is higher by RM12.16 mil if compare to it buy price during year 2012 at RM15.84 mil. Thus, in my opinion, nothing is bad for KPJ in this trade.
03/08/2020 12:21 AM
Virus t IHH- 15 hospitals in Malaysia total 2,372 beds (PE40)

KPJ- 28 hospitals in Malaysia total 3,200 beds (PE16)

TMC Life- 1 hospital in Malaysia total 600 beds (PE-Neg)

Every com hv it strength and opportunity.
IHH more expansion globally.
KPJ truly dominated Malaysia market in every states.
TMCLife is well-known healthcare sector in Singapore.
03/08/2020 7:36 AM
Virus t KPJ Indonesian hospitals recording revenue RM56.9Mil and Loss before tax 9.8Mil in 2019. Private healthcare mostly served T20 and M40 population thus higher living standard a country is more population willing to choose better healthcare system like Singapore.
03/08/2020 7:44 AM
captain star gogogo kpj..i am in again
03/08/2020 2:55 PM
nomadmy EPF is keep collecting KPJ. It is a good sign.
04/08/2020 12:46 PM
hksoon TA Securities research: buy call on Kpj Healthcare / Tp Rm0.95, 目标价调降至95仙,维持“买入”评级
Pesanan : Beli pada Kpj Healthcare oleh TA Securities dgn sikit diturunkan pd tahap harga Focus Rm0.95 , Sila ambil perhatian tuan -tuan dan puan - puan.
05/08/2020 9:12 PM
Investeye Will Budget 2021 benefit KPJ?
https://www.malaymail.com/news/malaysia/2020/08/05/2021-budget-to-focus-on-enhancing-education-entrepreneurship-healthcare-say/1891284
06/08/2020 9:16 AM
Investeye KPJ is getting more interesting for mid/long term:
- Worse is over (https://www.malaymail.com/news/money/2020/07/09/kpj-sees-gradual-recovery-in-public-healthcare-this-year/1883026)
- KPJ is potential to provide diagnostic test when the covid 19 Vaccine is ready to use (normally selected specialists or gov hospitals due to this vaccine new for the market)
- Health tourism will recover after the covid 19
- Revenue/Profit contribution from new opening outlets
- Focus of Budget 2021 in Healthcare
06/08/2020 9:39 AM
Virus t End game
Moderna prices Covid-19 vaccine at US$32-US$37 per dose for smaller-volume deals. https://www.theedgemarkets.com/article/moderna-prices-covid19-vaccine-us32us37-dose-smallervolume-deals
07/08/2020 7:50 AM
Takers The news since 1mnth ago,. Still downward trend
07/08/2020 12:34 PM
Takers This stock simpan dalam Laci first. Year end baru take out n inspection whether it turns into gold or otherwise
09/08/2020 10:23 PM
Shadows Sales is picking up this quater.
10/08/2020 4:41 PM
limkokthye kpj ready to boom, if vacine out, kpj will get it, faster buy
10/08/2020 7:42 PM
Virus t CGS CIMB expected total occupancy rates of about 52% for the financial year ending Dec 31,2020 (FY20), which is a slight dip from FY19’s occupancy rate of 67% https://www.thestar.com.my/business/business-news/2020/08/10/kpj-expected-to-see-recovery-in-occupancy.

Many broker expert try to predict how economy growth and now they are tried to predict how medical sector performance in the future although they have totally zero knowledge on health science.
11/08/2020 9:03 AM
Calvin882 Vaccine is available now. Would benefit healthcare sector
12/08/2020 1:50 PM
BASforce if u take the shoot which so call vaccine... i will believe u... but i will not that the shoot... kakakaka~
12/08/2020 8:03 PM
darkmagician Kpj will shoot up 1.5 before end of year.. no need vaccine.. covid swap test 388.. 3 month how many test they do
12/08/2020 11:01 PM
Virus t The best thing of being a Substantial Shareholder is they can receive daily, weekly, monthly and etc performance result of the company. CFO in-charge will email to them how company financially operated. EPF received 11% from employees salary and 12% from employers on monthly basic which need to be constantly invest in stock, bond and money market. They will choose a portfolio of good company to invest and in long term the value of the company performance will reflect to the stock price. Those company's price already reflected to the company performance will be selected to sell off and distributed to the pension package. We can look carefully how this system work and how to get some insider news to pick our own stock portfolio.
13/08/2020 5:22 PM